Showing 1 - 5 results of 5 for search 'Suzanne Hendrix', query time: 0.02s Refine Results
  1. 1
    FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”

    FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry” by Marwan N. Sabbagh, Suzanne Hendrix, John E. Harrison

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease

    Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease by Gil L’Italien, Basia Rogula, Lauren Powell, Michele Potashman, Samuel P. Dickson, Nick Kozauer, Patrick O’Keefe, Ellen Korol, Madeleine Crabtree, Fernanda Nagase, Vlad Coric, Jordan Dubow, Liana S. Rosenthal, Suzanne Hendrix

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Time saved in activities of daily living and whole‐brain volume: Post hoc analysis of a randomized feasibility trial of gamma oscillation treatment in participants with mild or moderate Alzheimer's disease

    Time saved in activities of daily living and whole‐brain volume: Post hoc analysis of a randomized feasibility trial of gamma oscillation treatment in participants with mild or mod... by Ralph Kern, Benjamin Haaland, Jessie Nicodemus‐Johnson, Samuel Dickson, Matthew Morgan, Joshua R. Christensen, Marwan N. Sabbagh, Lily Lee, Mihaly Hajós, Julia Riddle, Chandran V. Seshagiri, Christian Howell, Craig Mallinckrodt, Suzanne Hendrix

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease

    The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease by Cristina Lopez Lopez, Pierre N. Tariot, Angelika Caputo, Jessica B. Langbaum, Fonda Liu, Marie‐Emmanuelle Riviere, Carolyn Langlois, Marie‐Laure Rouzade‐Dominguez, Martin Zalesak, Suzanne Hendrix, Ronald G. Thomas, Vissia Viglietta, Rob Lenz, J. Michael Ryan, Ana Graf, Eric M. Reiman

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease

    Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease by Valentina R. Garbarino, Juan Pablo Palavicini, Justin Melendez, Nicolas R. Barthelemy, Yingxin He, Tiffany F. Kautz, Marisa Lopez-Cruzan, Julia J. Mathews, Peng Xu, Bin Zhang, Afaf Saliba, Nagarjunachary Ragi, Kumar Sharma, Dallin Mason, Samuel Johnson, Suzanne Hendrix, Suzanne Craft, Ronald C. Petersen, Jair Machado Espindola-Netto, Ailing Xue, Tamara Tchkonia, James L. Kirkland, Arash Salardini, Nicolas Musi, Randall J. Bateman, Mitzi M. Gonzales, Miranda E. Orr

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: